Inventor · disambiguated record
Laurie Goodman
Also filed as: GOODMAN LAURIE · GOODMAN LAURIE J
6 granted patents·7 pending applications·49 citations·filing 2003–2025
78Inventor score
Files withLABORATORY CORP AMERICA HOLDINGS5LAB CORP AMERICA HOLDINGS4PERSONALIS INC2CLEARLIGHT DIAGNOSTICS LLC1LYNX THERAPEUTICS INC1
Top patents by PatentIndex Score
13 records- 0195US8349574B2Methods of determining patient response by measurement of Her-3LAB CORP AMERICA HOLDINGS·Filed 2010·Granted Jan 8, 2013·42 cites·51 claims
- 0288US9766242B2Methods of determining patient response by measurement of HER-3 and P95LABORATORY CORP AMERICA HOLDINGS·Filed 2015·Granted Sep 19, 2017·3 cites·14 claims
- 0385US9110066B2HER-3 antibodies and methods of useLAB CORP AMERICA HOLDINGS·Filed 2012·Granted Aug 18, 2015·4 cites·34 claims
- 0471US12297508B2Customized assays for personalized cancer monitoringPERSONALIS INC·Filed 2022·Granted May 13, 2025·0 cites·25 claims
- 0571US2023062274A1Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer PatientsLABORATORY CORP AMERICA HOLDINGS·Filed 2022·Application pending·0 cites
- 0667US2025270653A1Customized assays for personalized cancer monitoringPERSONALIS INC·Filed 2025·Application pending·0 cites
- 0765US10775382B2Methods of determining patient response by measurement of HER-3LABORATORY CORP AMERICA HOLDINGS·Filed 2017·Granted Sep 15, 2020·0 cites·22 claims
- 0862US11401344B2Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patientsLABORATORY CORP AMERICA HOLDINGS·Filed 2018·Granted Aug 2, 2022·0 cites·11 claims
- 0960US2014370523A1Methods of Determining Patient Response by Measurement of HER-2 ExpressionLAB CORP AMERICA HOLDINGS·Filed 2014·Application pending·0 cites
- 1058US2017082626A1Methods of Determining Patient Response by Measurement of HER-2 ExpressionLABORATORY CORP AMERICA HOLDINGS·Filed 2016·Application pending·0 cites
- 1151US2003166026A1Identification of specific biomarkers for breast cancer cellsLYNX THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 1250US2010233732A1Methods of Determining Patient Response By Measurement of HER-2 ExpressionLAB CORP AMERICA HOLDINGS·Filed 2010·Application pending·0 cites
- 1339US2019113423A1Methods for preparing and analyzing tumor tissue samples for detection and monitoring of cancersCLEARLIGHT DIAGNOSTICS LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laurie Goodman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →